AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CMS Energy Corporation

$66.82 -$3.60 (-5.11%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$67.15
Day Range
$66.58$67.8
Year Range
$66.58$80.36
Market Cap
20.95B
AVG Volume
3.37M
Trailing/Forward PE
19.77/16.07
PEG ratio
2.66
Dividend Yield
3.37%
Next Earnings Date
2026-10-29
Primary Exchange
New York Stock ExchangeUS
Revenue (USD) · TTM
02.5B5B7.5B10B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q28.81B
26 Q18.82B
25 Q48.54B
25 Q38.29B
25 Q28.02B
25 Q17.79B
24 Q47.51B
24 Q37.48B
24 Q27.41B
24 Q17.35B
Net Income (USD) · TTM
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q21.03B
26 Q11.11B
25 Q41.07B
25 Q31.05B
25 Q21.02B
25 Q11.02B
24 Q41B
24 Q31.05B
24 Q2970M
24 Q1970M
Operating Income (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q21.67B
26 Q11.72B
25 Q41.73B
25 Q31.72B
25 Q21.6B
25 Q11.57B
24 Q41.49B
24 Q31.47B
24 Q21.37B
24 Q11.33B
EBITDA (USD) · TTM
01B2B3B4B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q23.12B
26 Q13.23B
25 Q43.19B
25 Q33.33B
25 Q23.22B
25 Q13.15B
24 Q43.08B
24 Q33.07B
24 Q22.96B
24 Q12.93B
Cash Flows (USD) · TTM
-3B-2B-1B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-1.91B
26 Q1-2.04B
25 Q4-1.59B
25 Q3-1.51B
25 Q2-1.38B
25 Q1-879M
24 Q4-648M
24 Q3-336M
24 Q2-249M
24 Q1-990M
EPS (USD) · TTM
0123424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q23.38
26 Q13.65
25 Q43.53
25 Q33.47
25 Q23.39
25 Q13.38
24 Q43.33
24 Q33.49
24 Q23.25
24 Q13.27
Expenses (USD) · TTM
-2.5B02.5B5B7.5B10BSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CMS Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q27.96B
26 Q17.88B
25 Q47.3B
25 Q33.71B
25 Q23.54B
25 Q13.29B
24 Q42.98B
24 Q32.62B
24 Q22.43B
24 Q13.13B
Dividends (USD)
00.20.40.6May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
CMS Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.57
May 260.57
Feb 260.57
Nov 250.54
Aug 250.54
May 250.54
Feb 250.54
Nov 240.52
Aug 240.52
May 240.52
Employee Count
02.5K5K7.5K10K2016201720182019202020212022202320242025
CMS Employee Count by quarter
PeriodEmployee Count
20258.35K
20248.32K
20238.36K
20228.56K
20218.5K
20208.15K
20198.79K
20188.62K
20177.95K
20167.8K
PE Ratio
181920212223med 20.7Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS PE Ratio by quarter
PeriodPE Ratio
Sep 2619.57
Sep 2619.67
Sep 2620.06
Aug 2619.98
Aug 2620
Aug 2620.83
Aug 2620.81
Jul 2621.09
Jul 2620.28
Jul 2620
Jul 2620.47
Jul 2621.1
Jun 2621.4
Jun 2619.92
Jun 2619.98
Jun 2619.56
May 2619.7
May 2620.24
May 2619.45
May 2619.71
May 2620.64
Apr 2621.4
Apr 2621.82
Apr 2622.28
Apr 2622.05
Mar 2621.39
Mar 2620.89
Mar 2621.84
Mar 2621.65
Feb 2621.91
Feb 2621.29
Feb 2621.54
Feb 2620.77
Jan 2620.38
Jan 2620.16
Jan 2620.44
Jan 2619.95
Jan 2620.08
Dec 2519.95
Dec 2519.72
Dec 2519.91
Dec 2520.27
Nov 2521.51
Nov 2521.11
Nov 2521.08
Nov 2520.88
Oct 2520.97
Oct 2521.81
Oct 2521.82
Oct 2521.62
Oct 2521.11
Sep 2520.96
Sep 2520.46
Sep 2520.92
Sep 2520.88
Aug 2520.88
Aug 2521.34
Aug 2521.1
Aug 2521.44
Aug 2521.62
Jul 2521.28
Jul 2521.03
Jul 2520.57
Jul 2520.6
Jun 2520.18
Jun 2520.19
Jun 2520.62
Jun 2520.46
May 2520.53
May 2520.36
May 2520.89
May 2521.13
May 2521.32
Apr 2521.1
Apr 2521.72
Apr 2521.39
Apr 2521.65
Mar 2522.1
Mar 2521.9
Mar 2521.68
Mar 2521.77
Feb 2521.76
Feb 2521.3
Feb 2520.5
Feb 2519.55
Jan 2518.79
Jan 2518.73
Jan 2519.38
Jan 2518.53
Jan 2518.96
Dec 2419.09
Dec 2418.96
Dec 2419.16
Dec 2419.12
Nov 2419.84
Nov 2419.79
Nov 2419.42
Nov 2419.14
Nov 2419.44
Oct 2421.73
Free Cash Flow Yield
-10%-7.5%-5%-2.5%0%med -6.43%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-9.51%
Sep 26-9.46%
Sep 26-9.28%
Aug 26-9.32%
Aug 26-9.31%
Aug 26-8.94%
Aug 26-8.95%
Jul 26-8.83%
Jul 26-9.06%
Jul 26-9.19%
Jul 26-8.98%
Jul 26-8.71%
Jun 26-8.59%
Jun 26-9.23%
Jun 26-9.2%
Jun 26-9.4%
May 26-9.33%
May 26-9.08%
May 26-9.45%
May 26-9.32%
May 26-8.91%
Apr 26-6.93%
Apr 26-6.8%
Apr 26-6.66%
Apr 26-6.73%
Mar 26-6.94%
Mar 26-7.1%
Mar 26-6.79%
Mar 26-6.85%
Feb 26-6.77%
Feb 26-6.97%
Feb 26-6.89%
Feb 26-6.94%
Jan 26-7.07%
Jan 26-7.15%
Jan 26-7.05%
Jan 26-7.22%
Jan 26-7.17%
Dec 25-7.22%
Dec 25-7.3%
Dec 25-7.23%
Dec 25-7.11%
Nov 25-6.7%
Nov 25-6.82%
Nov 25-6.83%
Nov 25-6.9%
Oct 25-6.87%
Oct 25-6.16%
Oct 25-6.16%
Oct 25-6.22%
Oct 25-6.37%
Sep 25-6.41%
Sep 25-6.57%
Sep 25-6.43%
Sep 25-6.44%
Aug 25-6.44%
Aug 25-6.3%
Aug 25-6.37%
Aug 25-6.27%
Aug 25-6.22%
Jul 25-4.05%
Jul 25-4.1%
Jul 25-4.19%
Jul 25-4.18%
Jun 25-4.27%
Jun 25-4.27%
Jun 25-4.18%
Jun 25-4.21%
May 25-4.2%
May 25-4.23%
May 25-4.12%
May 25-4.08%
May 25-4.04%
Apr 25-4.08%
Apr 25-2.97%
Apr 25-3.02%
Apr 25-2.98%
Mar 25-2.92%
Mar 25-2.95%
Mar 25-2.98%
Mar 25-2.97%
Feb 25-2.97%
Feb 25-3.03%
Feb 25-3.15%
Feb 25-1.64%
Jan 25-1.71%
Jan 25-1.71%
Jan 25-1.66%
Jan 25-1.73%
Jan 25-1.69%
Dec 24-1.68%
Dec 24-1.69%
Dec 24-1.67%
Dec 24-1.68%
Nov 24-1.62%
Nov 24-1.62%
Nov 24-1.65%
Nov 24-1.68%
Nov 24-1.65%
Oct 24-1.18%
Price to Sales
2.22.42.62.83med 2.68Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS Price to Sales by quarter
PeriodPrice to Sales
Sep 262.28
Sep 262.29
Sep 262.33
Aug 262.33
Aug 262.33
Aug 262.43
Aug 262.42
Jul 262.46
Jul 262.55
Jul 262.51
Jul 262.57
Jul 262.65
Jun 262.69
Jun 262.5
Jun 262.51
Jun 262.45
May 262.47
May 262.54
May 262.44
May 262.47
May 262.59
Apr 262.68
Apr 262.74
Apr 262.79
Apr 262.77
Mar 262.68
Mar 262.62
Mar 262.74
Mar 262.72
Feb 262.75
Feb 262.67
Feb 262.7
Feb 262.62
Jan 262.57
Jan 262.54
Jan 262.58
Jan 262.52
Jan 262.53
Dec 252.52
Dec 252.49
Dec 252.51
Dec 252.56
Nov 252.71
Nov 252.66
Nov 252.66
Nov 252.64
Oct 252.65
Oct 252.78
Oct 252.78
Oct 252.76
Oct 252.69
Sep 252.67
Sep 252.61
Sep 252.67
Sep 252.66
Aug 252.66
Aug 252.72
Aug 252.69
Aug 252.74
Aug 252.76
Jul 252.79
Jul 252.75
Jul 252.69
Jul 252.7
Jun 252.64
Jun 252.64
Jun 252.7
Jun 252.68
May 252.69
May 252.67
May 252.74
May 252.77
May 252.79
Apr 252.76
Apr 252.9
Apr 252.86
Apr 252.89
Mar 252.95
Mar 252.92
Mar 252.89
Mar 252.91
Feb 252.9
Feb 252.84
Feb 252.74
Feb 252.74
Jan 252.63
Jan 252.62
Jan 252.71
Jan 252.59
Jan 252.66
Dec 242.67
Dec 242.66
Dec 242.68
Dec 242.68
Nov 242.78
Nov 242.77
Nov 242.72
Nov 242.68
Nov 242.72
Oct 242.85
EV/EBITDA
1111.51212.51313.5med 12.09Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2612.53
Sep 2612.57
Sep 2612.69
Aug 2612.67
Aug 2612.67
Aug 2612.95
Aug 2612.94
Jul 2613.03
Jul 2612.77
Jul 2612.67
Jul 2612.84
Jul 2613.05
Jun 2613.15
Jun 2612.65
Jun 2612.67
Jun 2612.52
May 2612.57
May 2612.76
May 2612.49
May 2612.58
May 2612.9
Apr 2612.93
Apr 2613.07
Apr 2613.22
Apr 2613.15
Mar 2612.92
Mar 2612.76
Mar 2613.08
Mar 2613.01
Feb 2613.1
Feb 2612.89
Feb 2612.97
Feb 2611.84
Jan 2611.72
Jan 2611.65
Jan 2611.74
Jan 2611.59
Jan 2611.63
Dec 2511.59
Dec 2511.52
Dec 2511.58
Dec 2511.69
Nov 2512.08
Nov 2511.95
Nov 2511.94
Nov 2511.88
Oct 2511.91
Oct 2512.26
Oct 2512.26
Oct 2512.2
Oct 2512.03
Sep 2511.99
Sep 2511.83
Sep 2511.97
Sep 2511.96
Aug 2511.96
Aug 2512.11
Aug 2512.03
Aug 2512.14
Aug 2512.19
Jul 2512.13
Jul 2512.05
Jul 2511.9
Jul 2511.91
Jun 2511.77
Jun 2511.78
Jun 2511.92
Jun 2511.87
May 2511.89
May 2511.83
May 2512
May 2512.08
May 2512.14
Apr 2512.07
Apr 2512.41
Apr 2512.31
Apr 2512.39
Mar 2512.54
Mar 2512.47
Mar 2512.4
Mar 2512.43
Feb 2512.43
Feb 2512.28
Feb 2512.02
Feb 2511.8
Jan 2511.54
Jan 2511.52
Jan 2511.74
Jan 2511.45
Jan 2511.6
Dec 2411.64
Dec 2411.6
Dec 2411.67
Dec 2411.65
Nov 2411.9
Nov 2411.88
Nov 2411.75
Nov 2411.66
Nov 2411.76
Oct 2412.23
Price/Operating Cashflow
8101214med 9.75Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 269.35
Sep 269.4
Sep 269.58
Aug 269.54
Aug 269.55
Aug 269.95
Aug 269.94
Jul 2610.07
Jul 2611.57
Jul 2611.41
Jul 2611.68
Jul 2612.04
Jun 2612.21
Jun 2611.37
Jun 2611.4
Jun 2611.16
May 2611.24
May 2611.55
May 2611.1
May 2611.25
May 2611.78
Apr 2610.26
Apr 2610.46
Apr 2610.68
Apr 2610.57
Mar 2610.25
Mar 2610.01
Mar 2610.47
Mar 2610.38
Feb 2610.5
Feb 2610.2
Feb 2610.32
Feb 2610.07
Jan 269.88
Jan 269.77
Jan 269.91
Jan 269.67
Jan 269.73
Dec 259.67
Dec 259.56
Dec 259.65
Dec 259.82
Nov 2510.43
Nov 2510.23
Nov 2510.22
Nov 2510.12
Oct 2510.16
Oct 2510.52
Oct 2510.52
Oct 2510.43
Oct 2510.18
Sep 2510.11
Sep 259.87
Sep 2510.09
Sep 2510.07
Aug 2510.07
Aug 2510.29
Aug 2510.18
Aug 2510.34
Aug 2510.43
Jul 258.99
Jul 258.88
Jul 258.69
Jul 258.71
Jun 258.52
Jun 258.53
Jun 258.71
Jun 258.65
May 258.68
May 258.6
May 258.83
May 258.93
May 259.01
Apr 258.92
Apr 259.19
Apr 259.05
Apr 259.16
Mar 259.35
Mar 259.27
Mar 259.17
Mar 259.21
Feb 259.21
Feb 259.01
Feb 258.67
Feb 258.63
Jan 258.29
Jan 258.27
Jan 258.55
Jan 258.18
Jan 258.37
Dec 248.42
Dec 248.37
Dec 248.46
Dec 248.44
Nov 248.76
Nov 248.73
Nov 248.57
Nov 248.45
Nov 248.58
Oct 249.3
Price to Book
1.822.22.42.6med 2.35Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CMS Price to Book by quarter
PeriodPrice to Book
Sep 261.93
Sep 261.94
Sep 261.98
Aug 261.97
Aug 261.97
Aug 262.06
Aug 262.05
Jul 262.08
Jul 262.23
Jul 262.2
Jul 262.25
Jul 262.32
Jun 262.36
Jun 262.19
Jun 262.2
Jun 262.15
May 262.17
May 262.23
May 262.14
May 262.17
May 262.27
Apr 262.36
Apr 262.41
Apr 262.46
Apr 262.43
Mar 262.36
Mar 262.3
Mar 262.41
Mar 262.39
Feb 262.42
Feb 262.35
Feb 262.38
Feb 262.31
Jan 262.26
Jan 262.24
Jan 262.27
Jan 262.22
Jan 262.23
Dec 252.21
Dec 252.19
Dec 252.21
Dec 252.25
Nov 252.39
Nov 252.34
Nov 252.34
Nov 252.32
Oct 252.33
Oct 252.49
Oct 252.49
Oct 252.47
Oct 252.41
Sep 252.39
Sep 252.33
Sep 252.39
Sep 252.38
Aug 252.38
Aug 252.43
Aug 252.41
Aug 252.44
Aug 252.46
Jul 252.43
Jul 252.4
Jul 252.35
Jul 252.36
Jun 252.31
Jun 252.31
Jun 252.36
Jun 252.34
May 252.35
May 252.33
May 252.39
May 252.42
May 252.44
Apr 252.41
Apr 252.49
Apr 252.45
Apr 252.48
Mar 252.53
Mar 252.51
Mar 252.49
Mar 252.5
Feb 252.49
Feb 252.44
Feb 252.35
Feb 252.37
Jan 252.28
Jan 252.27
Jan 252.35
Jan 252.24
Jan 252.3
Dec 242.31
Dec 242.3
Dec 242.32
Dec 242.32
Nov 242.4
Nov 242.4
Nov 242.35
Nov 242.32
Nov 242.36
Oct 242.47
CMS Energy Corporation
CMS
Stockpicker

Video analysis: CMS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CMS

CMS Energy: Snatch Up This Future Dividend Aristocrat Now

seekingalpha.com · 8 Sep 2026

CMS Energy: Snatch Up This Future Dividend Aristocrat Now

CMS Energy remains positioned to become a Dividend Aristocrat early next decade. The regulated utility topped the analyst consensus for both operating revenue and adjusted EPS in the second quarter. CMS Energy possesses a BBB S&P credit rating with a stable outlook.

Nykredit A S Buys New Position in CMS Energy Corporation $CMS

defenseworld.net · 8 Sep 2026

Nykredit A S Buys New Position in CMS Energy Corporation $CMS

Nykredit A S bought a new stake in CMS Energy Corporation (NYSE: CMS) in the undefined quarter, according to its most recent disclosure with the SEC. The fund bought 17,941 shares of the utilities provider's stock, valued at approximately $1,372,000. A number of other institutional investors and hedge funds also recently bought and

CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)

globenewswire.com · 3 Sep 2026

CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)

SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) received the approval from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (Lumirix®) for the treatment of mild to moderate atopic dermatitis (“AD”) on 2 September 2026. The drug registration certificate was obtained on 3 September 2026. The product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Peter Thiel's Fund Reported Zero Stocks for 2 Straight Quarters. Its $419 Million Comeback Put 72% Into Energy and Power.

fool.com · 29 Aug 2026

Peter Thiel's Fund Reported Zero Stocks for 2 Straight Quarters. Its $419 Million Comeback Put 72% Into Energy and Power.

The fund reported nothing for six months. Its comeback filing lists one tech stock and seven energy bets.

Why Is CMS Energy (CMS) Down 6.9% Since Last Earnings Report?

zacks.com · 27 Aug 2026

Why Is CMS Energy (CMS) Down 6.9% Since Last Earnings Report?

CMS Energy (CMS) reported earnings 30 days ago. What's next for the stock?

Longstanding Bridgeline Customer Expands from CMS to HawkSearch AI Search and Shopping Assistant

accessnewswire.com · 25 Aug 2026

Longstanding Bridgeline Customer Expands from CMS to HawkSearch AI Search and Shopping Assistant

WOBURN, MA / ACCESS Newswire / August 25, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered product discovery and eCommerce solutions, announced today that a longstanding customer of its Content Management Platform has expanded its relationship with Bridgeline through the adoption of HawkSearch, including Concept and Unified Search, Smart Response, and Shopping Assistant. The multi-year engagement highlights growing demand for AI-powered search and assistant technologies among Bridgeline's existing customer base.

Peter Thiel's $418 Million Bet On These 8 Companies Reveals AI's Biggest Bottleneck

247wallst.com · 24 Aug 2026

Peter Thiel's $418 Million Bet On These 8 Companies Reveals AI's Biggest Bottleneck

Thiel Macro LLC resurfaced in mid-August with a $418.7 million book spread across exactly eight positions as of June 30, 2026, according to 13f.info's rendering of the filing.

Danske Bank A S Invests $1.53 Million in CMS Energy Corporation $CMS

defenseworld.net · 23 Aug 2026

Danske Bank A S Invests $1.53 Million in CMS Energy Corporation $CMS

Danske Bank A S acquired a new stake in CMS Energy Corporation (NYSE: CMS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 20,000 shares of the utilities provider's stock, valued at approximately $1,530,000. Other institutional investors have also

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.